Clinical Trials Browser

Terminated × Breast Neoplasms, Male × Docetaxel × Clear all

NCT00063934 2019-03-05

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Phase 1/2 Terminated

31 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00852332 2018-07-24

Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Breast Neoplasms, Male